Cargando…
Beyond the method change in clinical practice: evaluation of insulin-like growth factor I assay
OBJECTIVES: Insulin-like growth factor I (IGF-I) is the preferred biomarker for diagnosing and monitoring growth-related disorders but its serum quantification presents several difficulties since different IGF-I assays still leads to different IGF-I concentrations, especially when results are either...
Autores principales: | Sienes Bailo, Paula, Fabre Estremera, Marta, Cuenca Alcocel, José, César Márquez, María Ángeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197437/ https://www.ncbi.nlm.nih.gov/pubmed/37363432 http://dx.doi.org/10.1515/almed-2021-0069 |
Ejemplares similares
-
Más allá del cambio metodológico en la práctica clínica: Evaluación de las pruebas de factor de crecimiento insulínico tipo 1
por: Sienes Bailo, Paula, et al.
Publicado: (2022) -
Comparison and validation of ELISA assays for plasma insulin-like growth
factor-1 in the horse
por: Baskerville, Courtnay L., et al.
Publicado: (2017) -
Incidence of Huntington disease in a northeastern Spanish region: a 13-year retrospective study at tertiary care centre
por: Sienes Bailo, Paula, et al.
Publicado: (2020) -
Similarity of Serum and Plasma Insulin-like Growth Factor Concentrations
por: Houghton, Lauren C, et al.
Publicado: (2015) -
Comparison of Radioimmuno and Carbon Nanotube Field-Effect Transistor Assays for Measuring Insulin-Like Growth Factor-1 in a Preclinical Model of Human Breast Cancer
por: Jones, Laundette P, et al.
Publicado: (2011)